| Biological Sciences | Lifetime | 5 | FR 1 | 100.00 |
| Medical and Health Sciences | Lifetime | 148 | FR 2 | 99.99 |
| Biological Sciences | 2021-2025 | 661 | FR 11 | 99.31 |
| Infectious Diseases | Lifetime | 3 | FR 1 | 99.98 |
| Parasitology | Lifetime | 1 | FR 1 | 100.00 |
| Public, Environmental and Occupational Health | Lifetime | 50 | FR 1 | 99.93 |
| Clinical Biochemistry | Lifetime | 5 | FR 1 | 99.87 |
| Epidemiology | Lifetime | 59 | FR 2 | 99.90 |
| Molecular Biology | Lifetime | 153 | FR 5 | 99.93 |
| Endocrinology | Lifetime | 11 | FR 2 | 99.85 |
| Pathology and Forensic Medicine | Lifetime | 85 | FR 1 | 99.67 |
| Ecology | Lifetime | 150 | FR 8 | 99.67 |
| Genetics | Lifetime | 213 | FR 4 | 99.52 |
| Insect Science | Lifetime | 184 | FR 6 | 98.69 |
| Microbiology | Lifetime | 142 | FR 3 | 97.93 |
| Plant Science | Lifetime | 984 | FR 23 | 98.24 |
| Ecology, Evolution, Behavior and Systematics | Lifetime | 656 | FR 18 | 97.97 |
| Food Science and Technology | Lifetime | 642 | FR 16 | 97.96 |
| Molecular Medicine | Lifetime | 164 | FR 12 | 95.89 |
| Virology | Lifetime | 270 | FR 17 | 94.37 |
| Veterinary Science and Animal Health | Lifetime | 552 | FR 17 | 91.92 |
| Clinical Microbiology | Lifetime | 43 | FR 5 | 89.14 |
| Infectious Diseases | 2021-2025 | 46 | FR 1 | 99.41 |
| Molecular Biology | 2021-2025 | 535 | FR 10 | 97.22 |
| Epidemiology | 2021-2025 | 697 | FR 26 | 93.28 |
| Clinical Biochemistry | 2021-2025 | 39 | FR 1 | 89.11 |
| Parasitology | 2021-2025 | 140 | FR 5 | 86.31 |
| Viral Infections and Vectors | Lifetime | 1 | FR 1 | 100.00 |
| Streptococcal Infections and Treatments | Lifetime | 1 | FR 1 | 99.97 |
| Mosquito-borne diseases and control | Lifetime | 2 | FR 1 | 99.98 |
| Vector-borne infectious diseases | Lifetime | 1 | FR 1 | 100.00 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 1 | FR 1 | 99.98 |
| Vector-Borne Animal Diseases | Lifetime | 1 | FR 1 | 99.99 |
| Bacteriophages and microbial interactions | Lifetime | 4 | FR 1 | 99.94 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 1 | FR 1 | 99.98 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 5 | FR 1 | 99.95 |
| COVID-19 Clinical Research Studies | Lifetime | 16 | FR 1 | 99.88 |
| Dermatological diseases and infestations | Lifetime | 1 | FR 1 | 99.96 |
| Genomics and Phylogenetic Studies | Lifetime | 11 | FR 1 | 99.92 |
| Gut microbiota and health | Lifetime | 13 | FR 1 | 99.93 |
| Legionella and Acanthamoeba research | Lifetime | 1 | FR 1 | 99.79 |
| Mycobacterium research and diagnosis | Lifetime | 8 | FR 2 | 99.87 |
| Rabies epidemiology and control | Lifetime | 3 | FR 1 | 99.90 |
| Bartonella species infections research | Lifetime | 1 | FR 1 | 100.00 |
| Insect symbiosis and bacterial influences | Lifetime | 8 | FR 1 | 99.80 |
| Microbial infections and disease research | Lifetime | 15 | FR 1 | 99.65 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 42 | FR 1 | 99.76 |
| Zoonotic diseases and public health | Lifetime | 8 | FR 1 | 99.72 |
| Diphtheria, Corynebacterium, and Tetanus | Lifetime | 3 | FR 1 | 99.52 |
| Plant Virus Research Studies | Lifetime | 28 | FR 3 | 99.63 |
| Whipple's Disease and Interleukins | Lifetime | 1 | FR 1 | 99.88 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 19 | FR 3 | 99.69 |
| Leptospirosis research and findings | Lifetime | 4 | FR 1 | 99.64 |
| Bacillus and Francisella bacterial research | Lifetime | 11 | FR 1 | 99.50 |
| Probiotics and Fermented Foods | Lifetime | 47 | FR 2 | 99.68 |
| Long-Term Effects of COVID-19 | Lifetime | 77 | FR 3 | 99.04 |
| Toxoplasma gondii Research Studies | Lifetime | 28 | FR 2 | 99.35 |
| Plant and Fungal Interactions Research | Lifetime | 23 | FR 3 | 99.37 |
| Antibiotic Resistance in Bacteria | Lifetime | 152 | FR 11 | 99.41 |
| SARS-CoV-2 detection and testing | Lifetime | 53 | FR 3 | 98.50 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 107 | FR 5 | 99.37 |
| Vibrio bacteria research studies | Lifetime | 81 | FR 5 | 99.18 |
| Parasitic Infections and Diagnostics | Lifetime | 79 | FR 3 | 99.00 |
| Actinomycetales infections and treatment | Lifetime | 15 | FR 2 | 98.26 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 35 | FR 4 | 98.66 |
| Diet and metabolism studies | Lifetime | 706 | FR 18 | 98.76 |
| Infections and bacterial resistance | Lifetime | 32 | FR 2 | 98.40 |
| Viral gastroenteritis research and epidemiology | Lifetime | 543 | FR 17 | 98.47 |
| Insect and Pesticide Research | Lifetime | 501 | FR 18 | 98.25 |
| Parasites and Host Interactions | Lifetime | 223 | FR 5 | 98.29 |
| Bacterial biofilms and quorum sensing | Lifetime | 263 | FR 15 | 98.42 |
| Identification and Quantification in Food | Lifetime | 294 | FR 11 | 97.73 |
| Amoebic Infections and Treatments | Lifetime | 107 | FR 3 | 97.34 |
| Molecular Biology Techniques and Applications | Lifetime | 393 | FR 7 | 97.08 |
| Orthopedic Infections and Treatments | Lifetime | 402 | FR 10 | 98.00 |
| Respiratory viral infections research | Lifetime | 565 | FR 12 | 98.01 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 304 | FR 11 | 97.13 |
| Pericarditis and Cardiac Tamponade | Lifetime | 102 | FR 4 | 97.02 |
| Genital Health and Disease | Lifetime | 275 | FR 8 | 97.53 |
| Plant Pathogenic Bacteria Studies | Lifetime | 319 | FR 28 | 97.33 |
| Herpesvirus Infections and Treatments | Lifetime | 663 | FR 22 | 97.07 |
| Infectious Diseases and Mycology | Lifetime | 225 | FR 15 | 96.97 |
| Infectious Diseases and Tuberculosis | Lifetime | 421 | FR 17 | 96.73 |
| Microbial Community Ecology and Physiology | Lifetime | 763 | FR 42 | 97.76 |
| Reproductive tract infections research | Lifetime | 404 | FR 8 | 96.89 |
| Travel-related health issues | Lifetime | 90 | FR 7 | 96.53 |
| Oral microbiology and periodontitis research | Lifetime | 828 | FR 7 | 96.97 |
| Urinary Tract Infections Management | Lifetime | 559 | FR 11 | 96.70 |
| Viral Infections and Outbreaks Research | Lifetime | 466 | FR 24 | 95.99 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 430 | FR 12 | 95.62 |
| Plant Parasitism and Resistance | Lifetime | 982 | FR 28 | 95.47 |
| Fungal Infections and Studies | Lifetime | 951 | FR 44 | 94.66 |
| Nosocomial Infections in ICU | Lifetime | 598 | FR 74 | 94.62 |
| Plant pathogens and resistance mechanisms | Lifetime | 751 | FR 14 | 90.08 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 613 | FR 24 | 86.34 |
| Infectious Disease Case Reports and Treatments | Lifetime | 207 | FR 6 | 85.83 |
| Otolaryngology and Infectious Diseases | Lifetime | 546 | FR 15 | 83.99 |
| Drug-Induced Ocular Toxicity | Lifetime | 370 | FR 23 | 81.52 |
| Forensic Entomology and Diptera Studies | Lifetime | 850 | FR 21 | 83.66 |
| Insects and Parasite Interactions | Lifetime | 885 | FR 38 | 82.18 |
| Pneumothorax, Barotrauma, Emphysema | Lifetime | 472 | FR 14 | 78.20 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 167 | FR 4 | 69.23 |
| COVID-19 Clinical Research Studies | 2021-2025 | 86 | FR 2 | 99.47 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 107 | FR 2 | 99.46 |
| Long-Term Effects of COVID-19 | 2021-2025 | 249 | FR 10 | 97.19 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 117 | FR 9 | 95.77 |
| SARS-CoV-2 detection and testing | 2021-2025 | 246 | FR 11 | 94.97 |
| Genomics and Phylogenetic Studies | 2021-2025 | 365 | FR 12 | 94.65 |
| Animal Virus Infections Studies | 2021-2025 | 505 | FR 6 | 89.80 |
| Vector-borne infectious diseases | 2021-2025 | 383 | FR 20 | 89.88 |
| Whipple's Disease and Interleukins | 2021-2025 | 7 | FR 1 | 84.61 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 982 | FR 51 | 88.71 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 827 | FR 24 | 80.00 |
| Dermatological diseases and infestations | 2021-2025 | 132 | FR 11 | 78.02 |
| Streptococcal Infections and Treatments | 2021-2025 | 736 | FR 28 | 78.05 |
| Enterobacteriaceae and Cronobacter Research | 2021-2025 | 124 | FR 9 | 77.73 |
| Viral Infections and Outbreaks Research | 2021-2025 | 944 | FR 35 | 77.80 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 189 | FR 11 | 73.01 |
| Bacillus and Francisella bacterial research | 2021-2025 | 544 | FR 22 | 72.88 |
| Planarian Biology and Electrostimulation | 2021-2025 | 155 | FR 9 | 71.37 |
| Yersinia bacterium, plague, ectoparasites research | 2021-2025 | 556 | FR 28 | 68.34 |
| Bartonella species infections research | 2021-2025 | 102 | FR 6 | 65.88 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 112 | FR 9 | 60.18 |
| Diphtheria, Corynebacterium, and Tetanus | 2021-2025 | 345 | FR 17 | 35.95 |
| Infections and bacterial resistance | 2021-2025 | 730 | FR 31 | 29.10 |
